Cano Health, Inc. (CANWQ) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
9725 NW 117TH AVENUE, SUITE 200 MIAMI, FL 33178 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 18 | 0 | 1 | ||||
| Cash and cash equivalents | 0 | 1 | |||||
| Short-term investments | 18 | ||||||
| Receivables | 76 | 297 | 133 | ||||
| Inventory, net of allowances, customer advances and progress billings | 1 | ||||||
| Inventory | 1 | ||||||
| Prepaid expense | 0 | ||||||
| Other current assets | 13 | 19 | |||||
| Other undisclosed current assets | 76 | 25 | 182 | ||||
| Total current assets: | 183 | 341 | 317 | 1 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 78 | 178 | 132 | ||||
| Property, plant and equipment | 85 | ||||||
| Intangible assets, net (including goodwill) | 167 | 706 | 1,019 | ||||
| Goodwill | 480 | 770 | |||||
| Intangible assets, net (excluding goodwill) | 167 | 226 | 249 | ||||
| Asset, held-in-trust | 690 | ||||||
| Other noncurrent assets | 5 | 5 | 14 | ||||
| Other undisclosed noncurrent assets | 580 | 699 | 577 | ||||
| Total noncurrent assets: | 831 | 1,588 | 1,826 | 690 | |||
| TOTAL ASSETS: | 1,014 | 1,929 | 2,144 | 692 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 108 | 106 | 73 | ||||
| Accrued liabilities | 7 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 108 | 99 | 73 | ||||
| Deferred revenue | 2 | ||||||
| Debt | 1,161 | 2 | 1 | ||||
| Deferred compensation liability | 11 | ||||||
| Business combination, contingent consideration, liability | 3 | ||||||
| Other liabilities | 76 | 24 | 34 | ||||
| Other undisclosed current liabilities | 71 | 77 | 37 | 2 | |||
| Total current liabilities: | 1,415 | 208 | 161 | 2 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 7 | 1,001 | 1,040 | ||||
| Long-term debt, excluding current maturities | 998 | 915 | |||||
| Finance lease, liability | 7 | 3 | 2 | ||||
| Liabilities, other than long-term debt | 126 | 202 | 62 | ||||
| Deferred revenue | 4 | ||||||
| Other liabilities | 2 | 33 | 22 | ||||
| Operating lease, liability | 124 | 166 | 123 | ||||
| Business combination, contingent consideration, liability | 3 | 35 | |||||
| Other undisclosed noncurrent liabilities | 23 | 82 | 115 | ||||
| Total noncurrent liabilities: | 133 | 1,226 | 1,184 | 115 | |||
| Total liabilities: | 1,549 | 1,435 | 1,345 | 117 | |||
| Temporary equity, carrying amount | 570 | ||||||
| Equity | |||||||
| Equity, attributable to parent, including: | (348) | 253 | 319 | 5 | |||
| Additional paid in capital | 532 | 539 | 397 | 34 | |||
| Accumulated deficit | (880) | (286) | (79) | (29) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | 0 | 0 | |||
| Equity, attributable to noncontrolling interest | (187) | 242 | 480 | ||||
| Total equity: | (535) | 494 | 799 | 5 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,014 | 1,929 | 2,144 | 692 | |||
Income Statement (P&L) ($ in millions)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Revenues | 3,138 | 2,739 | 1,609 | |||
| Gross profit: | 3,138 | 2,739 | 1,609 | |||
| Operating expenses | (4,142) | (3,176) | (1,745) | (3) | ||
| Other undisclosed operating loss | (3) | |||||
| Operating loss: | (1,004) | (437) | (135) | (6) | ||
| Nonoperating income (expense) | (96) | 11 | 18 | 0 | ||
| Investment income, nonoperating | 1 | 0 | 0 | 0 | ||
| Other nonoperating income (expense) | 11 | 2 | (0) | |||
| Interest and debt expense | (115) | (1) | (13) | |||
| Loss from continuing operations before equity method investments, income taxes: | (1,215) | (428) | (130) | (5) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 115 | 1 | 13 | |||
| Loss from continuing operations before income taxes: | (1,101) | (426) | (117) | (5) | ||
| Income tax expense (benefit) | 2 | (2) | (0) | |||
| Loss from continuing operations: | (1,099) | (428) | (117) | (5) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (117) | (5) | |
| Other undisclosed net loss | (23) | |||||
| Net loss: | (1,099) | (428) | (117) | (29) | ||
| Net income attributable to noncontrolling interest | 504 | 221 | 99 | |||
| Net loss available to common stockholders, basic: | (594) | (207) | (18) | (29) | ||
| Dilutive securities, effect on basic earnings per share | ||||||
| Other undisclosed net loss available to common stockholders, diluted | (117) | |||||
| Net loss available to common stockholders, diluted: | (594) | (207) | (135) | (29) | ||
Comprehensive Income ($ in millions)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Net loss: | (1,099) | (428) | (117) | (29) | ||
| Comprehensive loss: | (1,099) | (428) | (117) | (29) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 504 | 221 | 99 | |||
| Comprehensive loss, net of tax, attributable to parent: | (594) | (207) | (18) | (29) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.